Memory and Mental Health in Aging

PHASE4CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Memory
Interventions
DRUG

Donepezil

"Participants received donepezil as 5mg pills per day for 6 weeks, then 10 mg per day for the remainder of the 52-week trial.~Participants also received 2 weeks of memory training at weeks 13-14"

DRUG

Placebos

"Participants received placebo as 5mg pills per day for 6 weeks, then 10 mg per day for the remainder of the 52-week trial.~Participants also received 2 weeks of memory training at weeks 13-14"

Trial Locations (1)

94304

VA Palo Alto Health Care System, Palo Alto

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Stanford University

OTHER

NCT02988908 - Memory and Mental Health in Aging | Biotech Hunter | Biotech Hunter